- Company Overview for NXERA PHARMA UK LIMITED (06267989)
- Filing history for NXERA PHARMA UK LIMITED (06267989)
- People for NXERA PHARMA UK LIMITED (06267989)
- Charges for NXERA PHARMA UK LIMITED (06267989)
- More for NXERA PHARMA UK LIMITED (06267989)
| Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
|---|---|---|---|
| 03 Jun 2026 | PSC02 | Notification of Nxera Pharma Co., Ltd. as a person with significant control on 6 April 2016 | |
| 03 Jun 2026 | PSC09 | Withdrawal of a person with significant control statement on 3 June 2026 | |
| 02 Jun 2026 | CS01 | Confirmation statement made on 30 May 2026 with no updates | |
| 29 Oct 2025 | MA | Memorandum and Articles of Association | |
| 23 Oct 2025 | RESOLUTIONS |
Resolutions
|
|
| 21 Oct 2025 | AP01 | Appointment of Dr Patrik Foerch as a director on 21 October 2025 | |
| 21 Oct 2025 | TM01 | Termination of appointment of Matthew Joseph Barnes as a director on 30 September 2025 | |
| 17 Oct 2025 | CH01 | Director's details changed for Candelle Wai Yee Chong on 30 March 2023 | |
| 16 Oct 2025 | CH01 | Director's details changed for Candelle Wai Yee Chong on 2 November 2023 | |
| 01 Aug 2025 | AA | Full accounts made up to 31 December 2024 | |
| 09 Jun 2025 | CS01 | Confirmation statement made on 30 May 2025 with no updates | |
| 25 Apr 2025 | AP01 | Appointment of Miss Mariko Nakafuji as a director on 1 April 2025 | |
| 29 Aug 2024 | AA | Full accounts made up to 31 December 2023 | |
| 17 Jun 2024 | CS01 | Confirmation statement made on 30 May 2024 with updates | |
| 02 Apr 2024 | CERTNM |
Company name changed heptares therapeutics LIMITED\certificate issued on 02/04/24
|
|
| 03 Aug 2023 | AA | Full accounts made up to 31 December 2022 | |
| 30 May 2023 | CS01 | Confirmation statement made on 30 May 2023 with no updates | |
| 18 Apr 2023 | AP01 | Appointment of Candelle Wai Yee Chong as a director on 30 March 2023 | |
| 06 Jan 2023 | SH19 |
Statement of capital on 6 January 2023
|
|
| 06 Jan 2023 | SH20 | Statement by Directors | |
| 06 Jan 2023 | CAP-SS | Solvency Statement dated 22/12/22 | |
| 06 Jan 2023 | RESOLUTIONS |
Resolutions
|
|
| 22 Sep 2022 | AA | Full accounts made up to 31 December 2021 | |
| 09 Jun 2022 | CS01 | Confirmation statement made on 4 June 2022 with no updates | |
| 13 May 2022 | AP01 | Appointment of Mr Matthew Joseph Barnes as a director on 24 March 2022 |